KoBioLabs, Inc (KOSDAQ:348150)

South Korea flag South Korea · Delayed Price · Currency is KRW
4,800.00
-20.00 (-0.41%)
At close: Jun 18, 2025, 3:30 PM KST
-31.23%
Market Cap 93.21B
Revenue (ttm) 70.75B
Net Income (ttm) -5.71B
Shares Out 19.42M
EPS (ttm) -295.84
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 51,046
Average Volume 25,375
Open 4,820.00
Previous Close 4,820.00
Day's Range 4,775.00 - 4,840.00
52-Week Range 3,730.00 - 8,920.00
Beta 0.67
RSI 46.75
Earnings Date Aug 14, 2025

About KoBioLabs

KoBioLabs, Inc. provides microbiome therapeutics for metabolic, immune, and neurological diseases. The company is based in Seongnam-si, South Korea. [Read more]

Industry Biological Products, Except Diagnostic Substances
CEO GwangPyo Ko
Country South Korea
Stock Exchange KOSDAQ
Ticker Symbol 348150
Full Company Profile

Financial Performance

In 2024, KoBioLabs's revenue was 68.36 billion, an increase of 106.28% compared to the previous year's 33.14 billion. Losses were -5.30 billion, -61.76% less than in 2023.

Financial Statements

News

There is no news available yet.